Forte Biosciences, Inc.

FBRX

$17.00

Name : Forte Biosciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $348,139,872.00

EPSttm : -4.58

Forte Biosciences, Inc.

$17.00

8.49%

$1.33

FBRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.8

Margin Of Safety %

Put/Call OI Ratio

0.86

EPS Next Q Diff

0.45

EPS Last/This Y

0.7

EPS This/Next Y

-0.13

Price

17.03

Target Price

63.75

Analyst Recom

Performance Q

-39.87

Upside

-490.8%

Beta

2.9

Ticker: FBRX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	FBRX	25.93	0.18	0.71	1644
2026-05-12	FBRX	24.15	0.18	26.00	1656
2026-05-13	FBRX	24.53	0.18	999.99	1666
2026-05-14	FBRX	23.8	0.20	1.20	1690
2026-05-15	FBRX	23.1	0.20	19.75	1698
2026-05-18	FBRX	21.02	1.23	1.54	272
2026-05-19	FBRX	19.97	1.28	1.10	338
2026-05-20	FBRX	20.25	1.26	1.33	402
2026-05-21	FBRX	22.08	1.26	0.75	415
2026-05-22	FBRX	21.7	1.26	0.50	424
2026-05-26	FBRX	21.87	1.25	2.00	426
2026-05-27	FBRX	21.4	1.15	0.76	446
2026-05-28	FBRX	20.84	1.09	2.75	511
2026-05-29	FBRX	19	1.14	1.00	519
2026-06-02	FBRX	18.21	1.01	1.00	544
2026-06-03	FBRX	16.93	1.01	0.88	547
2026-06-04	FBRX	16.59	0.99	0.28	556
2026-06-05	FBRX	16.56	0.88	0.13	580
2026-06-08	FBRX	15.78	0.88	1.38	585
2026-06-09	FBRX	17.07	0.86	2.00	606
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	FBRX	25.94	15.3	-	-4.26
2026-05-12	FBRX	24.22	15.3	-	-4.26
2026-05-13	FBRX	24.60	15.3	-	-4.26
2026-05-14	FBRX	24.02	15.3	-	-4.26
2026-05-15	FBRX	23.06	15.3	-	-4.26
2026-05-18	FBRX	20.95	-9.4	-	-4.17
2026-05-19	FBRX	20.01	-9.4	-	-4.17
2026-05-20	FBRX	20.30	-4.9	-	-4.17
2026-05-21	FBRX	22.07	-4.9	-	-4.01
2026-05-22	FBRX	21.62	-4.9	-	-4.01
2026-05-26	FBRX	21.87	-4.9	-	-4.01
2026-05-27	FBRX	21.43	-4.9	-	-4.01
2026-05-28	FBRX	20.82	-4.9	-	-4.01
2026-05-29	FBRX	19.05	-4.9	-	-4.01
2026-06-01	FBRX	19.02	-4.9	-	-4.01
2026-06-02	FBRX	18.20	-4.9	-	-4.01
2026-06-03	FBRX	16.98	-4.9	-	-4.01
2026-06-04	FBRX	16.69	-4.9	-	-4.01
2026-06-05	FBRX	16.56	-4.9	-	-4.01
2026-06-08	FBRX	15.78	-4.9	-	-4.01
2026-06-09	FBRX	17.03	-4.9	-	-4.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	FBRX	0.38	3.55	4.95
2026-05-12	FBRX	0.38	3.55	6.09
2026-05-13	FBRX	0.38	3.55	6.09
2026-05-14	FBRX	0.38	3.55	6.09
2026-05-15	FBRX	0.38	3.55	6.09
2026-05-18	FBRX	0.38	2.53	5.77
2026-05-19	FBRX	0.60	2.53	5.77
2026-05-20	FBRX	0.60	2.53	5.77
2026-05-21	FBRX	0.60	2.53	6.00
2026-05-22	FBRX	0.42	2.53	6.00
2026-05-26	FBRX	0.42	11.23	6.11
2026-05-27	FBRX	0.35	11.23	6.11
2026-05-28	FBRX	0.35	11.23	6.80
2026-05-29	FBRX	0.35	11.23	6.80
2026-06-02	FBRX	0.35	10.78	6.80
2026-06-03	FBRX	0.35	10.78	6.80
2026-06-04	FBRX	0.35	10.78	6.80
2026-06-05	FBRX	0.35	10.78	6.80
2026-06-08	FBRX	0.35	10.78	6.80
2026-06-09	FBRX	0.35	10.78	6.80
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.45

Avg. EPS Est. Current Quarter

-1.01

Avg. EPS Est. Next Quarter

-1

Insider Transactions

0.35

Institutional Transactions

10.78

Beta

2.9

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.4

Max Drawdown 5-Year %

-99.6

Target Price

63.75

P/E

Forward P/E

PEG

P/S

P/B

5.62

P/Free Cash Flow

EPS

-5.11

Average EPS Est. Cur. Y

-4.01

EPS Next Y. (Est.)

-4.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.42

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-4

EPS 1 30Days Diff

-4.01

EBIT Estimation

◆ FBRX Healthcare

$17.00

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

17/25

Volume

3/15

Valuation

12/20

TP/AR

2/10

Options

2/10

RSI

Range 1M

12.7%

Sup Dist

10.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

8/30

Estimates

0/20

Inst/Vol

8/15

Options

4/10

EPS Yr

12.8%

EPS NY

-3.6%

52W%

29.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +275% upside

Quality

2/30

Valuation

16/30

Growth

5/25

Stability

7/10

LT Trend

1/5

Upside

+275%

Quality

Forte Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 22

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

FBRX

Latest News

—

Caricamento notizie per FBRX…

stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today

news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance

stock history FBRX – Forte Biosciences Inc invest stock market

stock prices FBRX premarket after hours

ticker FBRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: FBRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y